Magnetic resonance susceptibility based perfusion imaging of tumors using iron oxide nanoparticles-Reference-Cited by-同舟云学术

Magnetic resonance susceptibility based perfusion imaging of tumors using iron oxide nanoparticles

Published:2008-11-20 Issue:1 Volume:1 Page:84-97
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Pathak Arvind P.¹²

Affiliation:

1. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University In Vivo Cellular Molecular Imaging Center (JHU ICMIC), Baltimore, MD, USA.

2. Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.17

Reference72 articles.

1. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

2. Tumor Angiogenesis: Therapeutic Implications

3. Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy

4. Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?

5. Differentiation and definition of vascular‐targeted therapies;Siemann DW;Clin Cancer Res,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular phenotyping of the invasive front in breast cancer using a 3D angiogenesis atlas;Microvascular Research;2023-09

2. MR contrast agents for perfusion imaging;Advances in Magnetic Resonance Technology and Applications;2023

3. Imaging the microvessel caliber and density: Principles and applications of microvascular MRI;Magnetic Resonance in Medicine;2014-08-28

4. Synthesis and Characterization of Fe-Based Metal and Oxide Based Nanoparticles: Discoveries and Research Highlights of Potential Applications in Biology and Medicine;Recent Patents on Nanotechnology;2014-03-31

5. Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model;Cancer Chemotherapy and Pharmacology;2013-05-07